If you made any changes in Pure these will be visible here soon.

Research Output 1973 2020

Filter
Article
2020

Khorana score and thromboembolic risk in stage II–III colorectal cancer patients: a post hoc analysis from the adjuvant TOSCA trial

Barni, S., Rosati, G., Lonardi, S., Pella, N., Banzi, M., Zampino, M. G., Dotti, K. F., Rimassa, L., Marchetti, P., Maiello, E., Artioli, F., Ferrari, D., Labianca, R., Bidoli, P., Zaniboni, A., Sobrero, A., Iaffaioli, V., De Placido, S., Frassineti, G. L., Ciarlo, A. & 11 others, Buonadonna, A., Silvestris, N., Piazza, E., Pavesi, L., Moroni, M., Clerico, M., Aglietta, M., Giordani, P., Galli, F., Galli, F. & Petrelli, F., Jan 1 2020, In : Therapeutic Advances in Medical Oncology. 12

Research output: Contribution to journalArticle

Open Access
Colorectal Neoplasms
Adjuvant Chemotherapy
Confidence Intervals
Logistic Models
Survival
2019

Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients

Peraldo-Neia, C., Scatolini, M., Grosso, E., Lombardi, P., Filippi, R., Raggi, C., Marchiò, C., Cavalloni, G., Aglietta, M. & Leone, F., Mar 30 2019, In : Cancers. 11, 4

Research output: Contribution to journalArticle

Cholangiocarcinoma
Disease Progression
Mutation
DNA
Polymerase Chain Reaction

Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients

Peraldo-Neia, C., Scatolini, M., Grosso, E., Lombardi, P., Filippi, R., Raggi, C., Marchiò, C., Cavalloni, G., Aglietta, M. & Leone, F., Mar 30 2019, In : Cancers. 11, 4

Research output: Contribution to journalArticle

Cholangiocarcinoma
Disease Progression
Mutation
DNA
Polymerase Chain Reaction

Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)

Atkinson, V., Sandhu, S., Hospers, G., Long, G. V., Aglietta, M., Ferrucci, P. F., Tulyte, S., Cappellini, G. C. A., Soriano, V., Ali, S., Poprach, A., Cesas, A., Rodriguez-Abreu, D., Lau, M., de Jong, E., Legenne, P., Stein, D., King, B. & van Thienen, J. V., Dec 30 2019, In : Melanoma Research.

Research output: Contribution to journalArticle

Melanoma
Therapeutics
Compassionate Use Trials
Neoplasm Metastasis
Disease-Free Survival

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program

Martin-Algarra, S., Hinshelwood, R., Mesnage, S., Cebon, J., Ferrucci, P. F., Aglietta, M., Neyns, B., Chiarion-Sileni, V., Lindsay, C. R., Del Vecchio, M., Linardou, H., Merelli, B., Tonini, G., Atkinson, V., Freivogel, K., Stein, D., Dalland, L., Lau, M., Legenne, P., Queirolo, P. & 1 others, Millward, M., 2019, In : Melanoma Research. 29, 5, p. 527-532 6 p.

Research output: Contribution to journalArticle

Melanoma
Confidence Intervals
Therapeutics
Disease-Free Survival
Fever

Effectiveness of dabrafenib in the treatment of patients with BRAF V600-mutated metastatic melanoma in a Named Patient Program.

Martin-Algarra, S., Hinshelwood, R., Mesnage, S., Cebon, J., Ferrucci, P. F., Aglietta, M., Neyns, B., Chiarion-Sileni, V., Lindsay, C. R., Del Vecchio, M., Linardou, H., Merelli, B., Tonini, G., Atkinson, V., Freivogel, K., Stein, D., Dalland, L., Lau, M., Legenne, P., Queirolo, P. & 1 others, Millward, M., Oct 1 2019, In : Melanoma Research. 29, p. 527-532 6 p.

Research output: Contribution to journalArticle

gemcitabine
Cholangiocarcinoma
Cell Line
Doxycycline
Paclitaxel
gemcitabine
Cholangiocarcinoma
Cell Line
Doxycycline
Paclitaxel

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

TOSCA (Three or Six Colon Adjuvant) Investigators, Mar 2019, In : The oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

oxaliplatin
Metformin
Colonic Neoplasms
Drug Therapy
Survival

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 20 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F., Di Bartolomeo, M. & Investigators, TOSCA. T. O. S. C. A., Mar 2019, In : The oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

oxaliplatin
Metformin
Colonic Neoplasms
Drug Therapy
Survival

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 18 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F. & Di Bartolomeo, M., 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis.

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 20 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F., Di Bartolomeo, M. & Investigators, TOSCA. T. O. S. C. A., Mar 1 2019, In : The oncologist. 24, p. 385-393 9 p.

Research output: Contribution to journalArticle

Improvement of Metastatic Colorectal Cancer Patient Survival: Single Institution Experience

Fenocchio, E., Colombi, F., Calella, M. G., Filippi, R., Depetris, I., Chilà, G., Lombardi, P., Marino, D., Cagnazzo, C., Ferraris, R., Vaira, M., Aglietta, M. & Leone, F., Mar 15 2019, In : Cancers. 11, 3

Research output: Contribution to journalArticle

Colorectal Neoplasms
Survival
Multivariate Analysis
Survival Rate
Liver

Met inhibition revokes IFNγ-induction of PD-1 ligands in MET-amplified tumours

Martin, V., Chiriaco, C., Modica, C., Acquadro, A., Cortese, M., Galimi, F., Perera, T., Gammaitoni, L., Aglietta, M., Comoglio, P. M., Vigna, E. & Sangiolo, D., Mar 2019, In : British Journal of Cancer. 120, 5, p. 527-536 10 p.

Research output: Contribution to journalArticle

Interferons
Ligands
Neoplasms
Organoids
Therapeutics

Preventing Venous Thromboembolism in Patients with Cancer

D'Ambrosio, L., Aglietta, M. & Grignani, G., May 30 2019, In : The New England journal of medicine. 380, 22, p. 2180-2181 2 p.

Research output: Contribution to journalArticle

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

Cesne, A. L., Bauer, S., Demetri, G. D., Han, G., Dezzani, L., Ahmad, Q., Blay, J-Y., Judson, I., Schöffski, P., Aglietta, M., Hohenberger, P. & Gelderblom, H., Aug 13 2019, In : BMC Cancer. 19, 1, p. 794

Research output: Contribution to journalArticle

Sarcoma
Safety
Disease-Free Survival
pazopanib
Therapeutics

Safe Use of Carfilzomib in a Patient with Multiple Myeloma and Intermittent Type 1 Brugada ECG Pattern: A Case Report

Ghisoni, E., Marandino, L., Lombardi, P., Bonzano, A., Becco, P., Aglietta, M., Fizzotti, M., Gay, F. & Rota Scalabrini, D., Sep 25 2019, In : Acta Haematologica. p. 1-5 5 p.

Research output: Contribution to journalArticle

Brugada Syndrome
Multiple Myeloma
Electrocardiography
Fever
Therapeutics

"Shades of Gray" in pancreatic ductal adenocarcinoma: Reappraisals on resectability criteria: Debated indications for surgery in pancreatic cancer.

Lombardi, P., Silvestri, S., Marino, D., Santarelli, M., Campra, D., De Paolis, P., Aglietta, M., Leone, F. & d’Aosta, R. O. P. E. V., Jan 1 2019, In : Critical Reviews in Oncology/Hematology. 133, p. 17-24 8 p.

Research output: Contribution to journalArticle

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer

Salati, M., Filippi, R., Vivaldi, C., Caputo, F., Leone, F., Salani, F., Cerma, K., Aglietta, M., Fornaro, L., Sperti, E., Di Maio, M., Ortega, C., Fenocchio, E., Lombardi, P., Cagnazzo, C., Depetris, I., Gelsomino, F., Spallanzani, A., Santini, D., Silvestris, N. & 5 others, Aprile, G., Roviello, G., Scartozzi, M., Cascinu, S. & Casadei-Gardini, A., Nov 27 2019, In : Liver international : official journal of the International Association for the Study of the Liver.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Nutrition Assessment
gemcitabine
Drug Therapy
Survival

The prognostic nutritional index predicts survival and response to first-line chemotherapy in advanced biliary cancer

Salati, M., Filippi, R., Vivaldi, C., Caputo, F., Leone, F., Salani, F., Cerma, K., Aglietta, M., Fornaro, L., Sperti, E., Di Maio, M., Ortega, C., Fenocchio, E., Lombardi, P., Cagnazzo, C., Depetris, I., Gelsomino, F., Spallanzani, A., Santini, D., Silvestris, N. & 5 others, Aprile, G., Roviello, G., Scartozzi, M., Cascinu, S. & Casadei-Gardini, A., Nov 27 2019, In : Liver International.

Research output: Contribution to journalArticle

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers

Ghisoni, E., Maggiorotto, F., Borella, F., Mittica, G., Genta, S., Giannone, G., Katsaros, D., Sciarrillo, A., Ferrero, A., Sarotto, I., Erriquez, J., Di Renzo, M. F., Aglietta, M. & Valabrega, G., Feb 13 2019, In : Journal of Ovarian Research. 12, 1, p. 17

Research output: Contribution to journalArticle

Doxorubicin
Platinum
Ovarian epithelial cancer
Therapeutics
Paraffin

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Fornaro, L., Leone, F., Vienot, A., Casadei-Gardini, A., Vivaldi, C., Lièvre, A., Lombardi, P., De Luca, E., Vernerey, D., Sperti, E., Musettini, G., Satolli, M. A., Edeline, J., Spadi, R., Neuzillet, C., Falcone, A., Pasquini, G., Clerico, M., Passardi, A., Buscaglia, P. & 5 others, Meurisse, A., Aglietta, M., Brac, C., Vasile, E. & Montagnani, F., 2019, In : Clinical Colorectal Cancer. 18, 4, p. e394-e401

Research output: Contribution to journalArticle

Validated Nomogram Predicting 6-Month Survival in Pancreatic Cancer Patients Receiving First-Line 5-Fluorouracil, Oxaliplatin, and Irinotecan

Fornaro, L., Leone, F., Vienot, A., Casadei-Gardini, A., Vivaldi, C., Lièvre, A., Lombardi, P., De Luca, E., Vernerey, D., Sperti, E., Musettini, G., Satolli, M. A., Edeline, J., Spadi, R., Neuzillet, C., Falcone, A., Pasquini, G., Clerico, M., Passardi, A., Buscaglia, P. & 5 others, Meurisse, A., Aglietta, M., Brac, C., Vasile, E. & Montagnani, F., Dec 2019, In : Clinical Colorectal Cancer. 18, 4, p. e394-e401

Research output: Contribution to journalArticle

oxaliplatin
irinotecan
Nomograms
Pancreatic Neoplasms
Fluorouracil

Veliparib: a new therapeutic option in ovarian cancer?

Ghisoni, E., Giannone, G., Tuninetti, V., Genta, S., Scotto, G., Aglietta, M., Sangiolo, D., Mittica, G. & Valabrega, G., Jun 1 2019, In : Future Oncology. 15, p. 1975-1987 13 p.

Research output: Contribution to journalArticle

2018

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: A two- centers experience

Ghisoni, E., Katsaros, D., Maggiorotto, F., Aglietta, M., Vaira, M., De Simone, M., Mittica, G., Giannone, G., Robella, M., Genta, S., Lucchino, F., Marocco, F., Borella, F., Valabrega, G. & Ponzone, R., May 30 2018, In : Journal of Ovarian Research. 11, 1, 42.

Research output: Contribution to journalArticle

Drug Therapy
Disease-Free Survival
Residual Neoplasm
Ovarian epithelial cancer
Neoplasms

Bone metastases in biliary cancers: A multicenter retrospective survey

Santini, D., Brandi, G., Aprile, G., Russano, M., Cereda, S., Leone, F., Lonardi, S., Fornaro, L., Scartozzi, M., Silvestris, N., Barni, S., Pantano, F., Vincenzi, B., Palloni, A., Frega, G., Casagrande, M., Ferrari, L., Dadduzio, V., Intini, R., Filippi, R. & 7 others, Vasile, E., Vivaldi, C., Faloppi, L., Brunetti, O., Reni, M., Aglietta, M. & Tonini, G., Sep 1 2018, In : Journal of Bone Oncology. 12, p. 33-37 5 p.

Research output: Contribution to journalArticle

Bone metastases in biliary cancers: A multicenter retrospective survey

Santini, D., Brandi, G., Aprile, G., Russano, M., Cereda, S., Leone, F., Lonardi, S., Fornaro, L., Scartozzi, M., Silvestris, N., Barni, S., Pantano, F., Vincenzi, B., Palloni, A., Frega, G., Casagrande, M., Ferrari, L., Dadduzio, V., Intini, R., Filippi, R. & 7 others, Vasile, E., Vivaldi, C., Faloppi, L., Brunetti, O., Reni, M., Aglietta, M. & Tonini, G., Sep 2018, In : Journal of Bone Oncology. 12, p. 33-37 5 p.

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
Bone Neoplasms
Diphosphonates
Neoplasm Metastasis
Bone and Bones

BRAF and MEK inhibitors increase PD-1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti–PD-1 antibody

Sanlorenzo, M., Vujic, I., Floris, A., Novelli, M., Gammaitoni, L., Giraudo, L., Macagno, M., Leuci, V., Rotolo, R., Donini, C., Basirico, M., Quaglino, P., Fierro, M. T., Giordano, S., Sibilia, M., Carnevale-Schianca, F., Aglietta, M. & Sangiolo, D., Jul 15 2018, In : Clinical Cancer Research. 24, 14, p. 3377-3385 9 p.

Research output: Contribution to journalArticle

Mitogen-Activated Protein Kinase Kinases
Melanoma
Lymphocytes
Antibodies
Recurrence

BRAF-inhibitors can exert control of disease in BRAF T599I mutated melanoma: a case report

Gallo, S., Coha, V., Caravelli, D., Becco, P., Venesio, T., Zaccagna, A., Giacone, E., Marenco, F., Pisacane, A., Racca, M., Gammaitoni, L., Aglietta, M. & Carnevale-Schianca, F., Apr 1 2018, In : Melanoma Research. 28, 2, p. 143-146 4 p.

Research output: Contribution to journalArticle

Melanoma
Mutation
Codon
Valine
Therapeutics

Cardiovascular safety of abiraterone acetate in metastatic castration-resistant prostate cancer patients: A prospective evaluation

Prati, V., Ruatta, F., Aversa, C., Gernone, A., Galizia, D., Bonzano, A., Torino, S., Nuzzolese, I., Marandino, L., Aglietta, M. & Ortega, C., Feb 1 2018, In : Future Oncology. 14, 5, p. 443-448 6 p.

Research output: Contribution to journalArticle

Castration
Prostatic Neoplasms
Safety
Coronary Artery Disease
Comorbidity

CD44v6 as innovative sarcoma target for CAR-redirected CIK cells

Leuci, V., Casucci, G. M., Grignani, G., Rotolo, R., Rossotti, U., Vigna, E., Gammaitoni, L., Mesiano, G., Fiorino, E., Donini, C., Pisacane, A., ambrosio, L. D., Pignochino, Y., Aglietta, M., Bondanza, A. & Sangiolo, D., May 4 2018, In : OncoImmunology. 7, 5, e1423167.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Antigen Receptors
Sarcoma
Heterografts
Neoplasms

Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy.

Mesiano, G., Grignani, G., Fiorino, E., Leuci, V., Rotolo, R., D’Ambrosio, L., Salfi, C., Gammaitoni, L., Giraudo, L., Pisacane, A., Butera, S., Pignochino, Y., Basiricó, M., Capozzi, F., Sapino, A., Aglietta, M. & Sangiolo, D., Nov 2 2018, In : OncoImmunology. 7, 11, e1465161.

Research output: Contribution to journalArticle

Cytokine-Induced Killer Cells
Neoplastic Stem Cells
Sarcoma
Drug Therapy
Molecular Targeted Therapy

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016.

Marandino, L., La Salvia, A., Sonetto, C., De Luca, E., Pignataro, D., Zichi, C., Di Stefano, R. F., Ghisoni, E., Lombardi, P., Mariniello, A., Reale, M. L., Trevisi, E., Leone, G., Muratori, L., Marcato, M., Bironzo, P., Novello, S., Aglietta, M., Scagliotti, G. V., Perrone, F. & 1 others, Di Maio, M., Dec 1 2018, In : Annals of oncology : official journal of the European Society for Medical Oncology. 29, p. 2288-2295 8 p.

Research output: Contribution to journalArticle

Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer

Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H. J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M. B., Hendlisz, A., Neyns, B., Svrcek, M., Moss, R. A., Ledeine, J. M., Cao, Z. A., Kamble, S., Kopetz, S. & André, T., Mar 10 2018, In : Journal of Clinical Oncology. 36, 8, p. 773-779 7 p.

Research output: Contribution to journalArticle

Microsatellite Instability
DNA Mismatch Repair
Colorectal Neoplasms
Disease-Free Survival
Survival Rate

Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer

Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., Sawyer, M. B., Hendlisz, A., Neyns, B., Svrcek, M., Moss, R. A., Ledeine, J-M., Cao, Z. A., Kamble, S., Kopetz, S. & André, T., Mar 10 2018, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 36, 8, p. 773-779 7 p.

Research output: Contribution to journalArticle

Microsatellite Instability
DNA Mismatch Repair
Colorectal Neoplasms
Disease-Free Survival
Survival Rate

Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study

Garassino, M. C., Cho, B-C., Kim, J-H., Mazières, J., Vansteenkiste, J., Lena, H., Corral Jaime, J., Gray, J. E., Powderly, J., Chouaid, C., Bidoli, P., Wheatley-Price, P., Park, K., Soo, R. A., Huang, Y., Wadsworth, C., Dennis, P. A., Rizvi, N. A., Paz-Ares Rodriguez, L., Novello, S. & 133 others, Hiret, S., Schmid, P., Laack, E., Califano, R., Maemondo, M., Kim, S-W., Chaft, J., Vicente Baz, D., Berghmans, T., Kim, D-W., Surmont, V., Reck, M., Han, J-Y., Holgado Martin, E., Belda Iniesta, C., Oe, Y., Chella, A., Chopra, A., Robinet, G., Soto Parra, H., Thomas, M., Cheema, P., Katakami, N., Su, W-C., Kim, Y-C., Wolf, J., Lee, J-S., Saka, H., Milella, M., Ramos Garcia, I., Sibille, A., Yokoi, T., Kang, E. J., Atagi, S., Spaeth-Schwalbe, E., Nishio, M., Imamura, F., Gabrail, N., Veillon, R., Derijcke, S., Maeda, T., Zylla, D., Kubiak, K., Santoro, A., Uy, M. N., Lucien Geater, S., Italiano, A., Kowalski, D., Barlesi, F., Chen, Y-M., Spigel, D., Chewaskulyong, B., Garcia Gomez, R., Alvarez Alvarez, R., Yang, C-H., Hsia, T-C., Denis, F., Sakai, H., Vincent, M., Goto, K., Bosch-Barrera, J., Weiss, G., Canon, J-L., Scholz, C., Aglietta, M., Kemmotsu, H., Azuma, K., Bradbury, P., Feld, R., Chachoua, A., Jassem, J., Juergens, R., Palmero Sanchez, R., Malcolm, A., Vrindavanam, N., Kubota, K., Waller, C., Waterhouse, D., Coudert, B., Mark, Z., Satouchi, M., Chang, G-C., Herzmann, C., Chaudhry, A., Giridharan, S., Hesketh, P., Ikeda, N., Boccia, R., Iannotti, N., Haigentz, M., Reynolds, J., Querol, J., Nakagawa, K., Sugawara, S., Tan, E. H., Hirashima, T., Gettinger, S., Kato, T., Takeda, K., Juan Vidal, O., Mohn-Staudner, A., Panwalkar, A., Daniel, D., Kobayashi, K., Ladrera, G. E. I., Schulte, C., Sebastian, M., Cernovska, M., Coupkova, H., Havel, L., Pauk, N., Singh, J., Murakami, S., Csoszi, T., Losonczy, G., Price, A., Anderson, I., Iqbal, M., Torri, V., Juhasz, E., Khanani, S., Koubkova, L., Levy, B., Page, R., Bocskei, C., Crinò, L., Einspahr, D., Hagenstad, C., Juat, N., Overton, L., Garrison, M., Szalai, Z. & Investigators, ATLANTIC., 2018, In : The Lancet Oncology. 19, 4, p. 521-536 16 p.

Research output: Contribution to journalArticle

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

Gobbini, E., Pilotto, S., Pasello, G., Polo, V., Di Maio, M., Arizio, F., Galetta, D., Petrillo, P., Chiari, R., Matocci, R., Di Costanzo, A., Di Stefano, T. S., Aglietta, M., Cagnazzo, C., Sperduti, I., Bria, E. & Novello, S., Mar 2018, In : Clinical Lung Cancer. 19, 2, p. 191-198 8 p.

Research output: Contribution to journalArticle

Contracts
Lung Neoplasms
Clinical Trials
Organizations
Research

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer

Gobbini, E., Pilotto, S., Pasello, G., Polo, V., Di Maio, M., Arizio, F., Galetta, D., Petrillo, P., Chiari, R., Matocci, R., Di Costanzo, A., Di Stefano, T. S., Aglietta, M., Cagnazzo, C., Sperduti, I., Bria, E. & Novello, S., Mar 2018, In : Clinical Lung Cancer. 19, 2, p. 191-198 8 p.

Research output: Contribution to journalArticle

Contracts
Lung Neoplasms
Clinical Trials
Organizations
Research

Prognostic and predictive role of EGFR pathway alterations in biliary cancer patients treated with chemotherapy and anti-EGFR

Peraldo-Neia, C., Cavalloni, G., Fenocchio, E., Cagnazzo, C., Gammaitoni, L., Cereda, S., Nasti, G., Satolli, M. A., Aprile, G., Reni, M., Avallone, A., Spadi, R., Venesio, T., Martin, V., Doglioni, C., Frattini, M., Aglietta, M. & Leone, F., 2018, In : PLoS One. 13, 1, p. e0191593

Research output: Contribution to journalArticle

Biliary Tract Neoplasms
oxaliplatin
Chemotherapy
gemcitabine
Protein-Tyrosine Kinases

Self-evaluation of duration of adjuvant chemotherapy side effects in breast cancer patients: A prospective study

Galizia, D., Milani, A., Geuna, E., Martinello, R., Cagnazzo, C., Foresto, M., Longo, V., Berchialla, P., Solinas, G., Calori, A., Grasso, B., Volpone, C., Bertola, G., Parola, G., Tealdi, G., Giuliano, P. L., Ballari, A. M., Aglietta, M. & Montemurro, F., Sep 1 2018, In : Cancer Medicine. 7, 9, p. 4339-4344 6 p.

Research output: Contribution to journalArticle

Diagnostic Self Evaluation
Adjuvant Chemotherapy
Prospective Studies
Breast Neoplasms
Terminology

Survivin-peptide vaccination elicits immune response after allogeneic nonmyeloablative transplantation: A safe strategy to enhance the graft versus tumor effect

Circosta, P., Vitaggio, K., Elia, A. R., Todorovic, M., Sangiolo, D., Carnevale-Schianca, F., Vallario, A., Geuna, M., Aglietta, M. & Cignetti, A., Jul 1 2018, In : Immunotherapy. 10, 9, p. 753-767 15 p.

Research output: Contribution to journalArticle

Homologous Transplantation
Vaccination
Transplants
Peptides
Cell Transplantation

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

trabectedin
Sarcoma
Bone and Bones
olaparib
Neutropenia

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., 2018, In : The Lancet Oncology. 19, 10, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group.

Grignani, G., D'Ambrosio, L., Pignochino, Y., Palmerini, E., Zucchetti, M., Boccone, P., Aliberti, S., Stacchiotti, S., Bertulli, R., Piana, R., Miano, S., Tolomeo, F., Chiabotto, G., Sangiolo, D., Pisacane, A., Dei Tos, A. P., Novara, L., Bartolini, A., Marchesi, E., D'Incalci, M. & 4 others, Bardelli, A., Picci, P., Ferrari, S. & Aglietta, M., Oct 1 2018, In : The Lancet. Oncology. 19, p. 1360-1371 12 p.

Research output: Contribution to journalArticle

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., 2018, In : BMC Genomics. 19, 1

Research output: Contribution to journalArticle

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., Jun 5 2018, In : BMC Genomics. 19, 1

Research output: Contribution to journalArticle

Cholangiocarcinoma
Epithelial-Mesenchymal Transition
Genes
Cytoskeleton
Neoplasms

Transcriptomic analysis and mutational status of IDH1 in paired primary-recurrent intrahepatic cholangiocarcinoma

Peraldo-Neia, C., Ostano, P., Cavalloni, G., Pignochino, Y., Sangiolo, D., De Cecco, L., Marchesi, E., Ribero, D., Scarpa, A., De Rose, A. M., Giuliani, A., Calise, F., Raggi, C., Invernizzi, P., Aglietta, M., Chiorino, G. & Leone, F., Jun 5 2018, In : BMC Genomics. 19, 1, 440.

Research output: Contribution to journalArticle

Cholangiocarcinoma
Epithelial-Mesenchymal Transition
Genes
Cytoskeleton
Neoplasms
2017

Aandrogen receptor status predicts development of brain metastases in ovarian cancers

Mittica, G., Senetta, R., Scotto, G., Aglietta, M., Maggiorotto, F., Ghisoni, E., Genta, S., Boldorini, R., Manini, C., Morra, I., Buosi, R., Sapino, A., Cassoni, P. & Valabrega, G., Jan 1 2017, In : Oncotarget. 8, 25, p. 41143-41153 11 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Neoplasm Metastasis
Brain
Androgen Receptors
Estrogen Receptors

Alpha-fetoprotein elevation in NUT midline carcinoma: A case report

D'Ambrosio, L., Palesandro, E., Moretti, M., Pelosi, G., Fabbri, A., Carnevale Schianca, F., Aglietta, M. & Grignani, G., Apr 13 2017, In : BMC Cancer. 17, 1, 266.

Research output: Contribution to journalArticle

alpha-Fetoproteins
Nuclear Proteins
Testis
Carcinoma
Germ Cell and Embryonal Neoplasms